ABT241213P95000
- 0.01
- 0.000.00%
Abbott Laboratories Newsroom
Abbott Labs Extends Royal Dividend Run With 7.3% Increase
Abbott Labs Raises Quarterly Dividend to 59c From 55c >ABT
Express News | Abbott Increases Quarterly Dividend for 53Rd Consecutive Year
Press Release: Abbott Increases Quarterly Dividend for 53rd Consecutive Year
Nephron Adjusts Price Target on Abbott Laboratories to $120 From $118
Market Mania Won't Last. Buy These 8 Stocks to Weather the Storm, Analyst Says.
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
Oppenheimer Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Oppenheimer Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth?
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant From Abbott
Wells Fargo's 'Core' List: GOOGL, DIS, HD, WMT, and More!
Peering Into Abbott Laboratories's Recent Short Interest
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
Express News | beijing strong biotechnologies, inc.: obtained medical instruments registration certificate
Is Abbott Laboratories Stock Underperforming the Nasdaq?
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133